🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, randomized, double-blind, placebo-controlled, parallel-...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01225393
Treatments Being Tested
This study assess the genomics profiles in synovial biopsies obtained prior...
Status
Completed
Location
Adrien NZEUSSEU TOUKAP
Start Date
2020-11-12
Trial ID
NCT04645420
Treatments Being Tested
This randomized, double-blind, parallel group study compares the efficacy a...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01194414
Central nervous system (CNS) idiopathic inflammatory demyelinating diseases...
Status
Recruiting
Location
Beijing Tiantan Hospital
Start Date
2021-12-15
Trial ID
NCT05154370
Treatments Being Tested
A Canadian study to evaluate early use of adalimumab after methotrexate fai...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01162421
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of deucrav...
Status
Active Not Recruiting
Location
Local Institution - 0197
Start Date
2021-07-13
Trial ID
NCT04908202
Treatments Being Tested
The purpose of this study is to verify the superiority of ASP015K in combin...
Status
Completed
Location
Site CN00048
Start Date
2018-09-27
Trial ID
NCT03660059
Treatments Being Tested
The purpose of this study is to determine whether apremilast is safe and ef...
Status
Completed
Location
Arizona Research Center
Start Date
2010-12-09
Trial ID
NCT01307423
Treatments Being Tested
The study aims at determining adherence rate to DMARDS and predicting facto...
Status
Unknown
Location
Multiple Locations
Start Date
2019-11
Trial ID
NCT03316027
The current study will assess the real - life effectiveness of adalimumab i...
Status
Completed
Location
Rheumatology Clinic /ID# 54768
Start Date
2011-06-29
Trial ID
NCT01387802